Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): A model disease to study molecular aspects of endocrine autoimmunity

Clinical and Experimental Immunology

Volumn 135, Issue 3, 2004, Pages 348-357

  Peterson, P ^a,c,d   Pitkanen J ^a   Sillanpaa N ^a   Krohn, K ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b FIT Biotech Plc   (Finland)

^c UNIVERSITY OF TARTU   (Estonia)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

APECED; Disease model; Endocrine autoimmunity; Molecular

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; AUTOIMMUNE REGULATOR PROTEIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CELLULAR DISTRIBUTION; CLINICAL FEATURE; FETUS LIVER; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; LYMPH NODE; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATOR GENE; REVIEW; SPLEEN; THYMUS; TRANSCRIPTION INITIATION;

AUTOANTIGENS; AUTOIMMUNITY; ENDOCRINE SYSTEM; HUMANS; POLYENDOCRINOPATHIES, AUTOIMMUNE; THYMUS GLAND; TRANSCRIPTION FACTORS;

EID: 1542269618     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02384.x     Document Type: Review

References (94)

1. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with differen polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 1981; 60:355-62.
2. Blizzard RM, Kyle M. Studies of the adrenal antigens and antibodies in Addison's disease. J Clin Invest 1963; 42:1653-60.
3. Ahonen P, Myllärniemi S, Sipila I et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322:1829-36.
4. Perheentupa JAPS-I, /APECED, the clinical disease and therapy. Endocrinol Metabol Clin N Am 2002; 31:295-320.
5. Björses P, Aaltonen J, Vikman A et al. Genetic homogeneity of autoimmune polyglandular disease type I. Am J Human Genet 1996; 59:879-86.
6. Rosatelli MC, Meloni A, Devoto M et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 1998; 103:428-34.
7. Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 1992; 29:824-6.
8. Myhre AG, Halonen M, Eskelin P et al. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol 2001; 54:211-7.
9. Pearce SH, Cheetham TD. Autoimmune polyendocrinopathy syndrome type 1: treat with kid gloves. Clin Endocrinol 2001; 54:433-5.
10. Richman RA, Rosenthal IM, Solomon LM et al. Candidiasis and multiple endocrinopathy. With oral squamous cell carcinoma complications. Arch Dermatol 1975; 111:625-7.
11. Friedman TC, Thomas PM, Fleisher TA et al. Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I. Am J Med 1991; 91:625-30.
12. Starzyk J, Kumorowicz-Kopiec M, Kowalczyk M et al. Natural history of asplenism in APECED - patient report. J Pediatr Endocrinol Metab 2001; 14:443-9.
13. Krohn K, Perheentupa J, Heinonen E. Precipitating anti-adrenal antibodies in Addison's disease. Clin Immunol Immunopathol 1974; 3:59-68.
14. Irvine WJ, Barnes EW. Addison's disease, ovarian failure and hypoparathyroidism. Clin Endocrinol Metab 1975; 4:379-434.
15. Goudie RB, McDonald E, Anderson JR et al. Immunological features of idiopathic Addison's disease: characterization of the adrenocortical antigens. Clin Exp Immunol 1968; 3:119-31.
16. Krohn K, Uibo R, Aavik E et al. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17 alpha-hydroxylase. Lancet 1992; 339:770-3.
17. Winqvist O, Gustafsson J, Rorsman F et al. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest 1993; 92:2377-85.
18. Winqvist O, Karlsson FA, Kampe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339:1559-62.
19. Uibo R, Aavik E, Peterson P et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab 1994; 78:323-8.
20. Furmaniak J, Kominami S, Asawa T et al. Autoimmune Addison's disease - evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. J Clin Endocrinol Metabolism 1994; 79:1517-21.
21. Boscaro M, Betterle C, Volpato M et al. Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. J Clin Endocrinol Metabolism 1996; 81:2801-4.
22. Betterle C, Dal Pra C, Mantero F et al. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002; 23:327-64.
23. Weetman AP. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. Baillieres Clin Endocrinol Metabolism 1995; 9:157-74.
24. Li Y, Song YH, Rais N et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996; 97:910-4.
25. Gylling M, Kaariainen E, Vaisanen R et al. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex. J Clin Endocrinol Metab 2003; 88:4602-8.
26. Husebye ES, Gebre-Medhin G, Tuomi T et al. Autoantibodies against aromatic 1-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metabolism 1997; 82:147-50.
27. Ekwall O, Hedstrand H, Grimelius L et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998; 352:279-83.
28. Sköldberg F, Portela-Gomes GM, Grimelius L et al. Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. J Clin Endocrinol Metabolism 2003; 88:1445-52.
29. Hogenauer C, Meyer RL, Netto GJ et al. Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I. N Engl J Med 2001; 344:270-4.
30. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet 1997; 17:399-403.
31. Nagamine K, Peterson P, Scott HS et al. Positional cloning of the APECED gene. Nat Genet 1997; 17:393-8.
32. Mittaz L, Rossier C, Heino M et al. Isolation and characterization of the mouse Aire gene. Biochem Biophys Res Commun 1999; 255:483-90.
33. Sternsdorf T, Grotzinger T, Jensen K et al. Nuclear dots: actors on many stages. Immunobiology 1997; 198:307-31.
34. Sternsdorf T, Jensen K, Reich B et al. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem 1999; 274:12555-66.
35. Aasland R, Gibson TJ, Stewart FA. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 1995; 20:56-9.
36. Capili AD, Schultz DC, Rauscher, FJ III et al. Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J 2001; 20:165-77.
37. Pascual J, Martinez-Yamout M, Dyson HJ et al. Structure of the PHD zinc finger from human Williams-Beuren syndrome transcription factor. J Mol Biol 2000; 304:723-9.
38. Pitkänen J, Vähämurto P, Krohn K et al. Subcellular localization of the autoimmune regulator protein, characterization of nuclear targeting and transcriptional activation domain. J Biol Chem 2001; 276:19597-602.
39. Pitkänen J, Doucas V, Stemsdorf T et al. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem 2000; 275:16802-9.
40. Halonen M, Eskelin P, Myhre AG et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 2002; 87:2568-74.
41. Gibson TJ, Ramu C, Gemund C et al. The APECED polyglandular autoimmune syndrome protein, AIRE-1, contains the SAND domain and is probably a transcription factor. Trends Biochem Sci 1998; 23:242-4.
42. Bottomley MJ, Collard MW, Huggenvik JI et al. The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat Struct Biol 2001; 8:626-33.
43. Kumar PG, Laloraya M, Wang CY et al. The Autoimmune Regulator (AIRE) Is a DNA-binding Protein. J Biol Chem 2001; 276:41357-64.
44. Heery DM, Kalkhoven E, Hoare S et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997; 387:733-6.
45. Björses P, Pelto-Huikko M, Kaukonen J et al. Localization of the APECED protein in distinct nuclear structures. Hum Mol Genet 1999; 8:259-66.
46. Kogawa K, Nagafuchi S, Katsuta H et al. Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol Lett 2002; 80:195-8.
47. Heino M, Peterson P, Kudoh J et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 1999; 257:821-5.
48. Zuklys S, Balciunaite G, Agarwal A et al. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol 2000; 165:1976-83.
49. Blechschmidt K, Schweiger M, Wertz K et al. The mouse Aire gene: comparative genomic sequencing, gene organization, and expression. Genome Res 1999; 9:158-66.
50. Heino M, Peterson P, Sillanpaa N et al. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol 2000; 30:1884-93.
51. Ruan QG, Wang CY, Shi JD et al. Expression and alternative splicing of the mouse autoimmune regulator gene (Aire) J Autoimmun 1999; 13:307-13.
52. Halonen M, Pelto-Huikko M, Eskelin P et al. Subcellular location and expression pattern of autoimmune regulator (Aire), the mouse orthologue for human gene defective in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED). J Histochem Cytochem 2001; 49:197-208.
53. Cihakova D, Trebusak K, Heino M et al. Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED. Hum Mutat 2001; 18:225-32.
54. Sato K, Nakajima K, Imamura H et al. A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: case report and review of the literature in Japan. Endocrine J 2002; 49:625-33.
55. Pearce SH, Cheetham T, Imrie H et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet 1998; 63:1675-84.
56. Heino M, Peterson P, Kudoh J et al. APECED mutations in the autoimmune regulator (AIRE) gene. Hum Mutat 2001; 18:205-11.
57. Heino M, Scott HS, Chen Q et al. Mutation analyses of North American APS-1 patients. Hum Mutat 1999; 13:69-74.
58. Ward L, Paquette J, Seidman E et al. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 1999; 84:844-52.
59. Wang CY, Davoodi-Semiromi A, Huang W et al. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum Genet 1998; 103:681-5.
60. Scott HS, Heino M, Peterson P et al. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol 1998; 12:1112-9.
61. Meloni A, Perniola R, Faa V et al. Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy. J Clin Endocrinol Metab 2002; 87:841-6.
62. Cetani F, Barbesino G, Borsari S et al. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 2001; 86:4747-52.
63. Soderbergh A, Rorsman F, Halonen M et al. Autoantibodies against aromatic 1-amino acid decarboxylase identifies a subgroup of patients with Addison's disease. J Clin Endocrinol Metab 2000; 85:460-3.
64. Saugier-Veber P, Drouot N, Wolf LM et al. Identification of a novel mutation in the autoimmune regulator (AIRE-1) gene in a French family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Eur J Endocrinol 2001; 144:347-51.
65. Ishii T, Suzuki Y, Ando N et al. Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy. J Clin Endocrinol Metab 2000; 85:2922-6.
66. Björses P, Halonen M, Palvimo JJ et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet 2000; 66:378-92.
67. Vogel A, Strassburg CP, Deiss D et al. A Novel AIRE Mutation in an APECED Patient with Candidiasis, Adrenal Failure, Hepatitis, Diabetes Mellitus and Osteosclerosis. Exp Clin Endocrinol Diabetes 2003; 111:174-6.
68. Gylling M, Tuomi T, Bjorses P et al. ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2000; 85:4434-40.
69. Rinderle C, Christensen HM, Schweiger S et al. AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered subcellular distribution of mutants lacking the PHD zinc fingers. Hum Mol Genet 1999; 8:277-90.
70. Doucas V, Evans RM. The PML nuclear compartment and cancer. Biochim Biophys Acta 1996; 1288:M25-9.
71. Chan HM, La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 2001; 114:2363-73.
72. Janknecht R, Hunter T. Versatile molecular glue. Transcriptional control. Curr Biol 1996; 6:951-4.
73. Kamei Y, Xu L, Heinzel T et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996; 85:403-14.
74. Goldman PS, Tran VK, Goodman RH. The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Prog Horm Res 1997; 52:103-19.
75. Chakravarti D, LaMorte VJ, Nelson MC et al. Role of CBP/P300 in nuclear receptor signalling. Nature 1996; 383:99-103.
76. Ramsey C, Bukrinsky A, Peltonen L. Systematic mutagenesis of the functional domains of AIRE reveals their role in intracellular targeting. Human Mol Genet 2002; 11:3299-308.
77. Murumägi A, Vähämurto P, Peterson P. Characterization of regulatory elements and methylation pattern of the autoimmune regulator (AIRE) promoter. J Biol Chem 2003; 278:19784-90.
78. Gommerman JL, Browning JL. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nature Rev Immunol 2003; 3:642-55.
79. Browning JL, French LE. Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos. J Immunol 2002; 168:5079-87.
80. De Togni P, Goellner J, Ruddle NH et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994; 264:703-7.
81. Wang J, Fu YX. LIGHT (a cellular ligand for herpes virus entry mediator and lymphotoxin receptor)-mediated thymocyte deletion is dependent on the interaction between TCR and MHC/self-peptide. J Immunol 2003; 170:3986-93.
82. Chin RK, Lo JC, Kim O et al. Lymphotoxin pathway directs thymic Aire expression. Nat Immunol 2003; 4:1121-7.
83. Weih F, Caamano J. Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway. Immunol Rev 2003; 195:91-105.
84. Nabarra B, Andrianarison I. Thymus reticulum of autoimmune mice. 3. Ultrastructural study of NOD (non-obese diabetic) mouse thymus. Int J Exp Pathol 1991; 72:275-87.
85. Atlan-Gepner C, Naspetti M, Valero R et al. Disorganization of thymic medulla precedes evolution towards diabetes in female NOD mice. Autoimmunity 1999; 31:249-60.
86. Ramsey C, Winqvist O, Puhakka L et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002; 11:397-409.
87. Anderson MS, Venanzi ES, Klein L et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298:1395-401.
88. Derbinski J, Schulte A, Kyewski B et al. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2:1032-9.
89. Liston A, Lesage S, Wilson J et al. Aire regulates negative selection of organ-specific T cells. Nature Immunol 2003; 4:350-4.
90. Meriluoto T, Halonen M, Pelto-Huikko M. et al. The autoimmune regulator: a key toward understanding the molecular pathogenesis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Keio J Med 2001; 4:225-39.
91. Janeway CA, Travers P, Walport M et al. Immunobiology, 5th edn. New York: Garland Publishing, 2001.
92. Derudder E, Dejardin E, Pritchard LL et al. RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. J Biol Chem 2003; 278:23278-84.
93. Muller JR, Siebenlist U. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem 2003; 278:12006-12.
94. Mordmuller B, Krappmann D, Esen M et al. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. EMBO Reports 2003; 4:82-7.